RET enhancer haplotype-dependent remodeling of the human fetal gut development program.

Hirschsprung disease (HSCR) is associated with deficiency of the receptor tyrosine kinase RET, resulting in loss of cells of the enteric nervous system (ENS) during fetal gut development. The major contribution to HSCR risk is from common sequence variants in RET enhancers with additional risk from...

Full description

Saved in:
Bibliographic Details
Main Authors: Sumantra Chatterjee, Lauren E Fries, Or Yaacov, Nan Hu, Hanna E Berk-Rauch, Aravinda Chakravarti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-11-01
Series:PLoS Genetics
Online Access:https://doi.org/10.1371/journal.pgen.1011030
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839594261257912320
author Sumantra Chatterjee
Lauren E Fries
Or Yaacov
Nan Hu
Hanna E Berk-Rauch
Aravinda Chakravarti
author_facet Sumantra Chatterjee
Lauren E Fries
Or Yaacov
Nan Hu
Hanna E Berk-Rauch
Aravinda Chakravarti
author_sort Sumantra Chatterjee
collection DOAJ
description Hirschsprung disease (HSCR) is associated with deficiency of the receptor tyrosine kinase RET, resulting in loss of cells of the enteric nervous system (ENS) during fetal gut development. The major contribution to HSCR risk is from common sequence variants in RET enhancers with additional risk from rare coding variants in many genes. Here, we demonstrate that these RET enhancer variants specifically alter the human fetal gut development program through significant decreases in gene expression of RET, members of the RET-EDNRB gene regulatory network (GRN), other HSCR genes, with an altered transcriptome of 2,382 differentially expressed genes across diverse neuronal and mesenchymal functions. A parsimonious hypothesis for these results is that beyond RET's direct effect on its GRN, it also has a major role in enteric neural crest-derived cell (ENCDC) precursor proliferation, its deficiency reducing ENCDCs with relative expansion of non-ENCDC cells. Thus, genes reducing RET proliferative activity can potentially cause HSCR. One such class is the 23 RET-dependent transcription factors enriched in early gut development. We show that their knockdown in human neuroblastoma SK-N-SH cells reduces RET and/or EDNRB gene expression, expanding the RET-EDNRB GRN. The human embryos we studied had major remodeling of the gut transcriptome but were unlikely to have had HSCR: thus, genetic or epigenetic changes in addition to those in RET are required for aganglionosis.
format Article
id doaj-art-1610c01b07d940fa94e2d4a601f627ff
institution Matheson Library
issn 1553-7390
1553-7404
language English
publishDate 2023-11-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj-art-1610c01b07d940fa94e2d4a601f627ff2025-08-03T00:36:56ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042023-11-011911e101103010.1371/journal.pgen.1011030RET enhancer haplotype-dependent remodeling of the human fetal gut development program.Sumantra ChatterjeeLauren E FriesOr YaacovNan HuHanna E Berk-RauchAravinda ChakravartiHirschsprung disease (HSCR) is associated with deficiency of the receptor tyrosine kinase RET, resulting in loss of cells of the enteric nervous system (ENS) during fetal gut development. The major contribution to HSCR risk is from common sequence variants in RET enhancers with additional risk from rare coding variants in many genes. Here, we demonstrate that these RET enhancer variants specifically alter the human fetal gut development program through significant decreases in gene expression of RET, members of the RET-EDNRB gene regulatory network (GRN), other HSCR genes, with an altered transcriptome of 2,382 differentially expressed genes across diverse neuronal and mesenchymal functions. A parsimonious hypothesis for these results is that beyond RET's direct effect on its GRN, it also has a major role in enteric neural crest-derived cell (ENCDC) precursor proliferation, its deficiency reducing ENCDCs with relative expansion of non-ENCDC cells. Thus, genes reducing RET proliferative activity can potentially cause HSCR. One such class is the 23 RET-dependent transcription factors enriched in early gut development. We show that their knockdown in human neuroblastoma SK-N-SH cells reduces RET and/or EDNRB gene expression, expanding the RET-EDNRB GRN. The human embryos we studied had major remodeling of the gut transcriptome but were unlikely to have had HSCR: thus, genetic or epigenetic changes in addition to those in RET are required for aganglionosis.https://doi.org/10.1371/journal.pgen.1011030
spellingShingle Sumantra Chatterjee
Lauren E Fries
Or Yaacov
Nan Hu
Hanna E Berk-Rauch
Aravinda Chakravarti
RET enhancer haplotype-dependent remodeling of the human fetal gut development program.
PLoS Genetics
title RET enhancer haplotype-dependent remodeling of the human fetal gut development program.
title_full RET enhancer haplotype-dependent remodeling of the human fetal gut development program.
title_fullStr RET enhancer haplotype-dependent remodeling of the human fetal gut development program.
title_full_unstemmed RET enhancer haplotype-dependent remodeling of the human fetal gut development program.
title_short RET enhancer haplotype-dependent remodeling of the human fetal gut development program.
title_sort ret enhancer haplotype dependent remodeling of the human fetal gut development program
url https://doi.org/10.1371/journal.pgen.1011030
work_keys_str_mv AT sumantrachatterjee retenhancerhaplotypedependentremodelingofthehumanfetalgutdevelopmentprogram
AT laurenefries retenhancerhaplotypedependentremodelingofthehumanfetalgutdevelopmentprogram
AT oryaacov retenhancerhaplotypedependentremodelingofthehumanfetalgutdevelopmentprogram
AT nanhu retenhancerhaplotypedependentremodelingofthehumanfetalgutdevelopmentprogram
AT hannaeberkrauch retenhancerhaplotypedependentremodelingofthehumanfetalgutdevelopmentprogram
AT aravindachakravarti retenhancerhaplotypedependentremodelingofthehumanfetalgutdevelopmentprogram